https://www.cmlsupport.org.uk/daily1.0 https://www.cmlsupport.org.uk/section/resources2019-03-18T15:45Znever https://www.cmlsupport.org.uk/section/about-cml2017-11-22T11:43Zyearly https://www.cmlsupport.org.uk/section/10-facts-about-cml2017-06-28T09:14Znever https://www.cmlsupport.org.uk/article/cancer-drugs-fund2015-10-07T08:58Znever https://www.cmlsupport.org.uk/article/effect-proton-pump-inhibitor-pharmacokinetics-imatinib2015-10-13T12:08Znever https://www.cmlsupport.org.uk/event/kings-cml-patients-group-lab-tours2015-10-17T13:55Znever https://www.cmlsupport.org.uk/article/musculoskeletal-pain-tki-withdrawal-syndrome2015-11-05T11:58Znever https://www.cmlsupport.org.uk/event/online-broadcast-event-cml-patients-journey2015-11-06T16:16Znever https://www.cmlsupport.org.uk/article/re-emergence-interferon-%CE%B1-treatment-chronic-myeloid-leukemia2015-11-07T13:54Znever https://www.cmlsupport.org.uk/article/discontinuation-dasatinib-patients-chronic-myeloid-leukaemia-who-have-maintained-deep2015-11-11T11:40Znever https://www.cmlsupport.org.uk/article/laboratory-recommendations-scoring-deep-molecular-responses-following-treatment-chronic2016-04-30T11:42Znever https://www.cmlsupport.org.uk/clinical-trials/bfore2015-11-15T19:23Znever https://www.cmlsupport.org.uk/clinical-trials/dasfree2015-11-15T19:59Znever https://www.cmlsupport.org.uk/clinical-trials/panobinostat-lbh589-and-imatinib-mesylate-treating-patients-previously-treated2015-11-15T20:17Znever https://www.cmlsupport.org.uk/clinical-trials/epic2015-11-15T20:25Znever https://www.cmlsupport.org.uk/clinical-trials/nilotinib-and-lde225-treatment-chronic-or-accelerated-phase-myeloid-leukemia2015-11-15T20:44Znever https://www.cmlsupport.org.uk/clinical-trials/choices2015-11-15T20:34Znever https://www.cmlsupport.org.uk/clinical-trials/spirit-22015-11-15T20:40Znever https://www.cmlsupport.org.uk/article/ash-abstract-137-osteoarticular-pain-after-discontinuation-tyrosine-kinase-inhibitors-tki2015-12-09T11:54Znever https://www.cmlsupport.org.uk/article/prof-steve-obriens-summary-ash-20152015-12-17T14:01Znever https://www.cmlsupport.org.uk/article/international-cml-foundation-november-2015-newsletter2015-12-21T18:02Znever https://www.cmlsupport.org.uk/article/government-responds-cancer-drugs-fund-petition-blood-cancer2015-12-23T13:05Znever https://www.cmlsupport.org.uk/event/patient-support-meeting-catherine-lewis-centre-london-w122015-12-23T17:15Znever https://www.cmlsupport.org.uk/article/prognosis-long-term-survival-considering-disease-specific-death-patients-chronic-myeloid2016-01-06T20:00Znever https://www.cmlsupport.org.uk/article/5-years-nilotinib-offers-benefit-over-imatinib-cml2016-02-11T17:46Znever https://www.cmlsupport.org.uk/article/cell-marker-found-leukemia-initiating-capacity-chronic-myelogenous-leukemia2016-02-18T14:45Znever https://www.cmlsupport.org.uk/article/mtss1-protein-may-act-tumor-suppressor-downregulated-cml2016-02-20T17:30Znever https://www.cmlsupport.org.uk/article/tkis-cml-linked-vascular-events2016-02-20T17:40Znever https://www.cmlsupport.org.uk/article/tgf-alpha-il-6-levels-predict-responses-and-outcomes-cml2016-03-24T17:20Znever https://www.cmlsupport.org.uk/event/cml-patient-carers-meeting-hammersmith-hospital2016-03-31T09:25Znever https://www.cmlsupport.org.uk/article/dasatinib-commonly-induces-lymphocytosis-cml-patients2016-03-31T14:35Znever https://www.cmlsupport.org.uk/article/mtss1-critical-epigenetically-regulated-tumor-suppressor-cml2016-04-06T14:39Znever https://www.cmlsupport.org.uk/article/european-leukemianet-recommendations-management-cml2016-04-15T11:37Znever https://www.cmlsupport.org.uk/article/long-term-benefits-and-risks-frontline-nilotinib-vs-imatinib-chronic-myeloid-leukemia-02016-05-05T14:12Znever https://www.cmlsupport.org.uk/article/pegifn-improves-responses-dasatinib-newly-diagnosed-cml-patients2016-05-21T13:12Znever https://www.cmlsupport.org.uk/event/cml-patient-support-group-meeting-glasgow2016-05-31T19:57Znever https://www.cmlsupport.org.uk/event/uk-cml-patient-conference-20162016-06-03T15:19Znever https://www.cmlsupport.org.uk/videos/what-cml2016-06-04T13:25Znever https://www.cmlsupport.org.uk/clinical-trials/phase-i-study-oral-abl001-patients-cml-or-ph-all2016-06-04T14:46Znever https://www.cmlsupport.org.uk/event/hammersmith-hospital-cml-patient-group-meeting2016-06-16T15:35Znever https://www.cmlsupport.org.uk/videos/resistant-cml2016-06-23T15:59Znever https://www.cmlsupport.org.uk/videos/how-should-cp-phase-cml-management-be-influenced-rt-pcr-3-months2016-06-23T16:20Znever https://www.cmlsupport.org.uk/article/dasatinib-imatinib-resistant-or-intolerant-chronic-phase-chronic-myeloid-leukaemia-patients2016-07-18T19:33Znever https://www.cmlsupport.org.uk/videos/what-if-what-now2016-08-02T18:07Znever https://www.cmlsupport.org.uk/videos/what-if-what-now-living-cml2016-08-02T18:09Znever https://www.cmlsupport.org.uk/article/concept-treatment-free-remission-cml2016-08-04T15:35Znever https://www.cmlsupport.org.uk/article/european-leukemianet-recommendations-management-and-avoidance-adverse-events-treatment-cml2016-08-04T15:56Znever https://www.cmlsupport.org.uk/videos/detecting-cml-digital-pcr2016-08-26T18:12Znever https://www.cmlsupport.org.uk/videos/measuring-molecular-responses-tyrosine-kinase-inhibitors-chronic-myeloid-leukaemia-ecancer2016-08-26T18:16Znever https://www.cmlsupport.org.uk/article/impact-dose-intensity-ponatinib-selected-adverse-events-multivariate-analyses-pooled2016-09-02T13:54Znever https://www.cmlsupport.org.uk/article/combined-targeting-bcl-2-and-bcr-abl-tyrosine-kinase-eradicates-chronic-myeloid-leukemia2016-09-07T20:52Znever https://www.cmlsupport.org.uk/article/abl001-treating-cml-timothy-p-hughes-md2016-09-10T14:46Znever https://www.cmlsupport.org.uk/article/webcast-link-cml-patient-day-2016-saturday-24th-september2016-09-17T12:38Znever https://www.cmlsupport.org.uk/article/closer-cure-researchers-centres-us-and-scotland-have-discovered-ways-target-leukaemic-stem2016-09-17T10:36Znever https://www.cmlsupport.org.uk/section/cml-treatment-guidelines-tki2016-09-27T17:05Znever https://www.cmlsupport.org.uk/article/long-term-follow-french-stop-imatinib-stim1-study-patients-cml2016-11-15T11:48Znever https://www.cmlsupport.org.uk/article/outcomes-euro-ski-trial-and-british-destiny-study-reported-ash-meeting-san-diego-show2016-12-08T14:48Znever https://www.cmlsupport.org.uk/videos/mutation-screening2016-12-08T17:08Znever https://www.cmlsupport.org.uk/videos/molecular-monitoring-cml-getting-safe-place2016-12-08T17:09Znever https://www.cmlsupport.org.uk/article/increased-proportion-mature-nk-cells-associated-successful-imatinib-discontinuation-cml2016-12-13T17:29Znever https://www.cmlsupport.org.uk/article/adding-pioglitazone-could-improve-molecular-response-cml-patients2017-01-08T13:43Znever https://www.cmlsupport.org.uk/article/destiny-cml-patients-stable-molecular-responses-safely-halved-tki-dose2017-01-08T13:51Znever https://www.cmlsupport.org.uk/videos/brian-druker-meeting-new-challenges-cml-therapy2017-02-11T07:14Znever https://www.cmlsupport.org.uk/article/strategies-stopping-tkis-growing-clearer2017-04-02T14:34Zyearly https://www.cmlsupport.org.uk/article/maternal-fetal-and-neonatal-imatinib-levels-treatment-chronic-myeloid-leukemia-pregnancy2017-05-13T14:54Zyearly https://www.cmlsupport.org.uk/article/natural-killer-cell-counts-are-associated-molecular-relapse-free-survival-after-imatinib2017-06-27T13:09Zyearly https://www.cmlsupport.org.uk/article/treatment-free-remission-following-frontline-nilotinib-patients-cml-chronic-phase-results2017-07-08T16:15Zyearly https://www.cmlsupport.org.uk/article/striving-vanquish-leukaemia-combination-two-compounds-shows-promise-lab2017-07-20T16:39Zyearly https://www.cmlsupport.org.uk/article/frequency-rare-bcr-abl1-fusion-transcripts-chronic-myeloid-leukemia-patients2017-07-29T11:26Zyearly https://www.cmlsupport.org.uk/article/stopping-drug-therapy-cml-euro-ski-results2017-07-29T16:26Zyearly https://www.cmlsupport.org.uk/article/memoriam-tessa-holyoake2017-09-09T15:54Zyearly https://www.cmlsupport.org.uk/videos/treatment-outcomes-bosutinib-real-world-data2017-09-11T15:51Zyearly https://www.cmlsupport.org.uk/videos/factors-affecting-clinical-decision-making-refractory-and-relapsed-cp-cml-patients2017-09-11T15:52Zyearly https://www.cmlsupport.org.uk/videos/how-treat-cml-20172017-09-11T15:53Zyearly https://www.cmlsupport.org.uk/article/targeted-antibiotic-use-may-help-cure-chronic-myeloid-leukaemia2017-09-28T19:11Zyearly https://www.cmlsupport.org.uk/article/car-t-cells-engineering-patients-immune-cells-treat-their-cancer2017-11-02T16:20Zyearly https://www.cmlsupport.org.uk/publications2018-01-11T10:58Zyearly https://www.cmlsupport.org.uk/section/generic-imatinib-leaflet2017-12-06T14:53Zyearly https://www.cmlsupport.org.uk/section/pcr-booklet2018-01-17T12:02Zyearly https://www.cmlsupport.org.uk/article/once-day-nilotinib-real-life-observational-study2018-04-23T16:44Zyearly https://www.cmlsupport.org.uk/videos/dr-michael-mauro-expert-answers-your-cml-questions2018-01-31T13:11Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-perspectives-molecular-monitoring-cml-global-perspective2018-01-31T13:17Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-perspectives-molecular-monitoring-cml-perspectives-russia2018-01-31T13:16Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-qa-session-1-perspectives-molecular-monitoring-cml2018-01-31T13:16Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-perspectives-treatment-free-remission-global-perspective2018-01-31T13:18Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-perspectives-treatment-free-remission-perspectives-brazil2018-01-31T13:19Zyearly https://www.cmlsupport.org.uk/videos/icmlf-forum-2017-qa-session-2-perspectives-treatment-free-remission2018-01-31T13:20Zyearly https://www.cmlsupport.org.uk/article/pancreatic-enzyme-elevation-patients-treated-nilotinib2018-02-20T12:07Zyearly https://www.cmlsupport.org.uk/article/considerations-successful-treatment-free-remission2018-02-26T16:03Zyearly https://www.cmlsupport.org.uk/article/long-term-outcome-nilotinib-400-mg-twice-daily-first-line-treatment2018-03-01T16:04Zyearly https://www.cmlsupport.org.uk/article/dasatinib-dose-management-treatment-chronic-myeloid-leukemia2018-02-28T13:11Zyearly https://www.cmlsupport.org.uk/article/help-cml-support-registering-amazonsmile2018-03-01T16:33Zyearly https://www.cmlsupport.org.uk/article/early-results-lower-dose-dasatinib-50-mg-daily-frontline-therapy2018-05-06T10:00Zyearly https://www.cmlsupport.org.uk/article/cml-patients-deep-molecular-responses-tki-have-restored-immune-effectors-and-decreased-pd-12018-07-09T13:21Zyearly https://www.cmlsupport.org.uk/article/chronic-myeloid-leukemia-and-pregnancy-patient-and-partner-perspectives2018-07-29T16:12Zyearly https://www.cmlsupport.org.uk/live2018-09-25T21:15Zyearly https://www.cmlsupport.org.uk/article/pepsi-or-coke-influence-acid-dasatinib-absorption2018-08-21T16:23Zyearly https://www.cmlsupport.org.uk/article/bcr-abl1-levels-increase-peripheral-blood-not-granulocytes-after-physical-exercise2018-08-21T16:25Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-chronic-myeloid-leukaemia-what-it2018-09-25T19:47Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-imatinib-where-are-we-now-what-about-generic-imatinib2018-09-25T19:48Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-how-response-treatment-measured-pcr-assay2018-09-25T19:49Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-2nd-3rd-generation-tkis-nilotinib-dasatinib-ponatinib-bosutinib-when2018-09-25T19:50Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-questions-panel-session-12018-09-25T19:51Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-patient-stories-richard-willoughby2018-09-25T19:52Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-patient-stories-alastair-cameron2018-09-25T19:53Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-side-effects-and-how-manage-them2018-09-25T19:54Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-adherence-tki-therapy-still-problem2018-09-25T19:55Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-update-clinical-trials-and-what%E2%80%99s-new2018-09-25T19:55Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-questions-panel-session-22018-09-25T19:57Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-day-questions-panel-session-32018-09-26T07:41Zyearly https://www.cmlsupport.org.uk/videos/2018-uk-patient-daydestiny-clinical-trial-and-stopping-treatment-who-and-when-prof-richard2018-09-25T21:13Zyearly https://www.cmlsupport.org.uk/article/%C2%A33m-award-pioneering-scottish-trial-leukaemia-cml2018-09-27T15:10Zyearly https://www.cmlsupport.org.uk/article/uclh-study-web-based-video-consultations2018-12-13T13:00Zyearly https://www.cmlsupport.org.uk/article/e13a2-bcr-abl1-transcript-associated-higher-rates-molecular-recurrence-after-tfr-attempts2018-12-08T07:25Zyearly https://www.cmlsupport.org.uk/article/falsified-iclusig-ponatinib-traded-globally2019-03-05T15:50Zmonthly https://www.cmlsupport.org.uk/videos/making-tfr-mainstream2019-03-12T10:03Zmonthly https://www.cmlsupport.org.uk/videos/prognostic-biomarkers-cml2019-03-12T10:06Zmonthly https://www.cmlsupport.org.uk/videos/immunology-cml-and-immunomodulation2019-03-12T10:05Zmonthly https://www.cmlsupport.org.uk/videos/we-do-still-transplant-cml-dont-we2019-03-12T17:16Zmonthly https://www.cmlsupport.org.uk/videos/importance-molecular-monitoring-cml-how-deep-how-often-and-how-should-it-influence-therapy2019-03-12T17:17Zmonthly https://www.cmlsupport.org.uk/article/skeletal-muscle-toxicity-associated-tkis-cml-patients2019-03-18T15:39Zweekly https://www.cmlsupport.org.uk/article/tki-discontinuation-criteria-established-updated-nccn-guidelines2019-03-27T16:30Zhourly https://www.cmlsupport.org.uk/about/privacy-policy2015-07-28T14:31Znever https://www.cmlsupport.org.uk/organisations/imperial-college-healthcare-nhs-trust2015-07-28T15:15Znever https://www.cmlsupport.org.uk/clinical-trials/destiny2015-11-20T16:41Znever https://www.cmlsupport.org.uk/clinical-trials/abl001%E2%80%8B2015-11-20T17:11Znever https://www.cmlsupport.org.uk/section/testing-cml2015-07-28T14:14Znever https://www.cmlsupport.org.uk/section/inside-cell2015-09-17T13:58Znever https://www.cmlsupport.org.uk/section/about-qrt-pcr-test2015-07-28T14:13Znever https://www.cmlsupport.org.uk/section/bcr-abl1-gene-and-its-messenger-rna-protein-tyrosine-kinase-bcr-abl12015-07-28T14:16Znever https://www.cmlsupport.org.uk/section/how-q-pcr-testing-works-practice2015-07-28T14:26Znever https://www.cmlsupport.org.uk/section/testing-response-treatment2015-07-28T14:12Znever https://www.cmlsupport.org.uk/section/treating-cml2015-07-29T16:17Znever https://www.cmlsupport.org.uk/section/patient-information2017-11-22T12:48Zyearly https://www.cmlsupport.org.uk/section/side-effects-tki-therapies2017-11-22T11:51Znever https://www.cmlsupport.org.uk/clinical-trials/enestfreedom2015-07-28T14:31Znever https://www.cmlsupport.org.uk/clinical-trials/simplicity2015-07-28T14:31Znever https://www.cmlsupport.org.uk/clinical-trials/enestop2015-07-28T14:34Znever https://www.cmlsupport.org.uk/clinical-trials/euro-ski2015-09-16T18:02Znever https://www.cmlsupport.org.uk/clinical-trials/stim-22015-07-28T14:35Znever https://www.cmlsupport.org.uk/clinical-trials/cml1113-gimema2015-07-28T14:34Znever https://www.cmlsupport.org.uk/clinical-trials/dasapost2015-07-28T14:34Znever https://www.cmlsupport.org.uk/clinical-trials/enestpath2015-07-28T14:31Znever https://www.cmlsupport.org.uk/about2018-02-09T16:07Zyearly https://www.cmlsupport.org.uk/section/about-site2015-07-28T14:31Znever https://www.cmlsupport.org.uk/section/how-you-can-support-us2015-07-28T16:30Znever https://www.cmlsupport.org.uk/section/our-funding-policy2015-09-18T02:34Znever https://www.cmlsupport.org.uk/section/what-cml2015-09-17T13:59Znever https://www.cmlsupport.org.uk/section/about-philadelphia-chromosome2015-07-28T14:16Znever https://www.cmlsupport.org.uk/section/forum-usage-agreement2018-10-11T08:06Zyearly https://www.cmlsupport.org.uk/section/acknowledgments2015-09-18T02:34Znever https://www.cmlsupport.org.uk/section/normal-blood-counts2015-07-28T14:26Znever https://www.cmlsupport.org.uk/section/international-standardisation-test-results2015-09-21T22:12Znever https://www.cmlsupport.org.uk/section/templates2015-09-18T11:17Znever https://www.cmlsupport.org.uk/section/template-questions-blood-test-progress-updates2015-09-17T14:09Znever https://www.cmlsupport.org.uk/section/10-most-important-things-remember-about-cml-testing2015-09-21T22:11Znever https://www.cmlsupport.org.uk/section/how-ensure-you-have-optimal-response-tki-therapy2015-07-29T16:14Znever https://www.cmlsupport.org.uk/section/future-cml-testing2015-07-28T14:12Znever https://www.cmlsupport.org.uk/section/three-phases-cml2015-09-17T14:07Znever https://www.cmlsupport.org.uk/section/your-diagnosis-02017-11-22T11:52Zyearly https://www.cmlsupport.org.uk/section/template-questions-early-meetings-your-treatment-team2015-09-17T14:08Znever https://www.cmlsupport.org.uk/content/nigel-deekes2015-09-18T01:19Znever https://www.cmlsupport.org.uk/content/david-fitzgerald2018-02-20T12:06Zyearly https://www.cmlsupport.org.uk/content/karen-adams-walker2016-08-06T15:14Znever https://www.cmlsupport.org.uk/content/denise-clayson2015-09-18T01:20Znever https://www.cmlsupport.org.uk/content/olivia-bell2015-09-18T01:20Znever https://www.cmlsupport.org.uk/section/just-diagnosed2017-11-22T11:44Zyearly https://www.cmlsupport.org.uk/clinical-trials/dasision2015-07-29T13:54Znever https://www.cmlsupport.org.uk/videos/what-if-what-now-milestones-cml2016-08-02T18:11Znever https://www.cmlsupport.org.uk/content/richard-willoughby2015-09-14T10:29Znever https://www.cmlsupport.org.uk/section/recommended-books2015-09-18T11:16Znever https://www.cmlsupport.org.uk/content/sandy-craine2015-09-17T14:38Znever https://www.cmlsupport.org.uk/section/about-our-new-website2015-09-18T02:29Znever https://www.cmlsupport.org.uk/section/press-and-media2015-09-21T23:36Znever https://www.cmlsupport.org.uk/node/6242017-08-03T10:34Zyearly https://www.cmlsupport.org.uk/node/7322017-06-27T13:08Zyearly https://www.cmlsupport.org.uk/node/7942015-09-25T11:47Znever https://www.cmlsupport.org.uk/node/8032015-09-25T12:14Znever https://www.cmlsupport.org.uk/node/8382015-09-25T12:17Znever https://www.cmlsupport.org.uk/node/9092015-09-25T12:06Znever https://www.cmlsupport.org.uk/node/9542015-09-25T11:21Znever https://www.cmlsupport.org.uk/node/9552015-09-25T11:18Znever https://www.cmlsupport.org.uk/node/9772015-09-25T11:44Znever https://www.cmlsupport.org.uk/article/cancer-drugs-fund-cml-support-signatory-letter-times-november-4th-day-bosutinib-delisted2015-12-22T14:46Znever https://www.cmlsupport.org.uk/event/uk-patients-and-carers-day-20152016-04-05T11:37Znever https://www.cmlsupport.org.uk/section/templates-send-your-mp2015-09-25T16:13Znever